Aridis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
02/14 15:33 (美东)
Aridis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Lind Global Fund II LP(0%),Lind Global Partners II LLC(0%)等
02/13 20:06 (美东)
Aridis Pharmaceuticals | 8-K:重大事件
01/16 00:00 (美东)
Aridis Pharmaceuticals | DEFA14A:其他
2023/12/18 09:43 (美东)
Aridis Pharmaceuticals | 8-K:重大事件
2023/12/18 09:40 (美东)
Aridis Pharmaceuticals | DEFA14A:其他
2023/12/15 17:00 (美东)
Aridis Pharmaceuticals:2023财年三季报
2023/11/06 16:06 (美东)
Aridis Pharmaceuticals | 8-K:Aridis Pharmicals公布2023年第三季度财务业绩和业务最新情况
2023/11/03 17:00 (美东)
Aridis Pharmaceuticals | DEFA14A:其他
2023/11/03 06:15 (美东)
Aridis Pharmaceuticals | ARS:年度报告
2023/11/02 17:54 (美东)
Aridis Pharmaceuticals | DEF 14A:股东委托书决议
2023/11/02 17:51 (美东)
Aridis Pharmaceuticals | 4:持股变动声明-董事 HAMILTON JOHN F
2023/09/19 16:05 (美东)
Aridis Pharmaceuticals | 4:持股变动声明-董事 Windham-Bannister Susan Richards
2023/09/19 16:05 (美东)
Aridis Pharmaceuticals | 4:持股变动声明-董事会执行主席 Patzer Eric
2023/09/19 16:05 (美东)
Aridis Pharmaceuticals | 4:持股变动声明-高管 Truong Vu
2023/09/19 16:05 (美东)
Aridis Pharmaceuticals | 4:持股变动声明-高管 Jafri Hasan
2023/09/19 16:05 (美东)
Aridis Pharmaceuticals | 10-Q:2023财年二季报
2023/09/13 21:47 (美东)
Aridis Pharmaceuticals | 25-NSE:由交易所申报的注销已到期、已赎回、已兑付证券的通知
2023/09/08 10:13 (美东)
Aridis Pharmaceuticals | 8-K:重大事件
2023/09/07 16:15 (美东)
Aridis Pharmaceuticals | 8-K:重大事件
2023/08/25 16:05 (美东)
暂无数据
暂无数据